Yüklüyor......

Sodium-Glucose Cotransporter 2 Inhibitors Reduce Prandial Insulin Doses in Type 2 Diabetic Patients Treated With the Intensive Insulin Therapy

BACKGROUND: Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are anti-diabetic drugs which improve blood glucose control by blocking reabsorption of glucose from the proximal tubule of kidney. Anti-atherosclerotic properties and cardiovascular protective effects of SGLT2i have been demonstrated by...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Clin Med Res
Asıl Yazarlar: Hakoshima, Mariko, Yanai, Hidekatsu, Kakuta, Kouki, Adachi, Hiroki
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Elmer Press 2018
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5916538/
https://ncbi.nlm.nih.gov/pubmed/29707091
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14740/jocmr3392w
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!